SEATTLE, Nov. 2, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce a collaboration with Nature Immunology and Arkitek Studios to visualize TAP’s role in combating disease.
SEATTLE, Nov. 2, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce a collaboration with Nature Immunology and Arkitek Studios to visualize TAP’s role in combating disease.